Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAN 2020 | Mild cognitive impairment: biomarker counseling, diagnosis and follow-up

Kristian Steen Frederiksen • 26 May 2020
EAN 2020
Alzheimer’s Disease Dementia Mild Cognitive Impairment

Kristian Steen Frederiksen, MD, PhD, FEBN, Danish Dementia Research Centre, Rigshospitalet, Copenhagen, Denmark, outlines the results of an online survey performed among members of the European Alzheimer’s Disease Consortium (EADC) on biomarker counseling, disclosure of diagnosis and follow-up in patients with mild cognitive impairment (MCI). This interview was recorded during an online conference call with The Video Journal of Dementia (VJDementia).

More from Kristian Steen Frederiksen

Management needs of patients with dementia: sleep disorders & hip fractures
2:53
Management needs of patients with dementia: sleep disorders & hip fractures
Kristian Steen Frederiksen • 27 Jun 2022
Characterizing the prodromal phase of dementia with Lewy bodies
5:18
Characterizing the prodromal phase of dementia with Lewy bodies
Kristian Steen Frederiksen • 27 Jun 2022
Ethical considerations when investigating the causes of mild cognitive impairment
2:22
Ethical considerations when investigating the causes of mild cognitive impairment
Kristian Steen Frederiksen • 27 Jun 2022
EAN guidance on managing patients with dementia
2:27
EAN guidance on managing patients with dementia
Kristian Steen Frederiksen • 20 Nov 2020

Related Videos

A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
10:28
A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
Muhammad Umar Khan • 28 Aug 2026
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
3:25
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
Vikash Jaiswal • 26 Aug 2026
The Lewy Body Society's mission and impact
2:38
The Lewy Body Society's mission and impact
Jacqui Cannon • 5 Aug 2026
Neflamapimod receives ILAP designation in the UK for dementia with Lewy bodies
2:44
Neflamapimod receives ILAP designation in the UK for dementia with Lewy bodies
Jacqui Cannon • 5 Aug 2026

Choose your cookie settings

VJDementia uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJDementia is intended for healthcare professionals